Why your heart's shape matters more than its pumping speed
In short: Doctors traditionally diagnose heart failure by how much blood the heart pumps out. However, new research suggests that the physical geometry of the heart—specifically how the muscle thickens—might be a more critical predictor of how a patient responds to life-saving medications.
Heart failure is commonly categorized by the left ventricular ejection fraction (LVEF), a measure of pumping efficiency. However, the physical remodeling of the left ventricle (LV) provides a deeper look into the underlying pathology. Two primary types of remodeling exist: concentric hypertrophy and eccentric hypertrophy. While most patients with heart failure with reduced ejection fraction (HFrEF) exhibit eccentric hypertrophy, a significant subset develops concentric hypertrophy, which presents a distinct clinical and biomarker phenotype.
The difference lies in the structural adaptation of the heart muscle. Concentric hypertrophy is often associated with pressure overload, such as systemic hypertension, and is frequently seen in older patients. In contrast, eccentric hypertrophy is more common in HFrEF and is often linked to volume overload. These structural differences are not just anatomical; they influence the biological pathways the heart uses to cope with stress, involving different networks of biomarkers like N-terminal pro-B-type natriuretic peptide in eccentric cases.
This distinction has profound implications for treatment. A retrospective analysis of 1,015 patients in the BIOSTAT-CHF study revealed that up-titrating beta-blockers was associated with a mortality benefit in patients with eccentric hypertrophy, but not in those with concentric hypertrophy. Furthermore, the hazard ratio for mortality was higher in patients with concentric hypertrophy when using ACE inhibitors or ARBs, though the interaction was not statistically significant. Understanding these geometric nuances allows for a more precise approach to managing heart failure.
Ultimately, the research suggests that 'heart failure' is not a monolithic condition. By moving beyond ejection fractions to examine LV geometry, clinicians can better identify which patients will benefit from standard therapies and which may require different management strategies based on their specific heart remodeling patterns.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Concentric Hypertrophy vs. Eccentric Hypertrophy - Dilated, Hypertrophic (HOCM), Restrictive
- Also: Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment
To cite this card, link to https://intellectplus.co.uk/app/science-concentric-hypertrophy-vs-eccentric-hypertrophy-dilated-hype.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Science · Latest · A–Z · All topics
